Search results
New Covid Boosters Get a Thumbs-Up From FDA. Vaccine Stocks Are Wavering.
Barrons.com· 8 hours agoDrugmakers are aiming to launch this year’s shots by the beginning of September but have been...
Novavax's stock surges almost 300% in the past month
Yahoo Finance· 3 hours agoIf approved, Novavax would finally be able to market its only commercially available product during the fall vaccine season, alongside rivals Pfizer...
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga via Yahoo Finance· 3 days agoMonday, Moderna Inc (NASDAQ:MRNA) and Merck & Co Inc (NYSE:MRK) announced the first presentation of...
Moderna mRNA candidate chosen for FDA rare disease therapy acceleration program
Seeking Alpha· 9 hours agoThe FDA selects Moderna's mRNA therapeutic mRNA-3705 for a pilot program to accelerate development...
Moderna's Investigational Therapeutic for Methylmalonic Acidemia (mRNA-3705) Selected by U.S. Food &...
Morningstar· 12 hours agoCAMBRIDGE, MA / ACCESSWIRE / June 6, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has selected mRNA-3705 for the Support ...
Is Moderna Inc (NASDAQ: MRNA) Stock On Course For Another Boom Or Bust? – Marketing Sentinel
Marketing Sentinel· 16 hours agoDuring the last session, Moderna Inc (NASDAQ:MRNA)’s traded shares were 4.04 million, with the beta value of the company hitting 1.70. At the end of the trading day, the stock ...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 12 hours agoModerna’s respiratory syncytial virus (RSV) vaccine mRESVIA has received US Food and Drug...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 6 days agoModerna confirmed it's in discussions with the U.S. government to move forward with its bird flu...
Moderna Drug Candidate Tapped for FDA Rare-Disease Pilot Program
Morningstar· 11 hours agoBy Colin Kellaher Moderna's mRNA-3705 drug candidate for a rare, genetic disorder of the liver has been chosen for a Food and Drug Administration pilot program aimed at addressing ...
Is Moderna Inc. (NASDAQ:MRNA) the Top Gene Therapy Stock to Invest in Now?
Insider Monkey via Yahoo Finance· 3 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...